Intralesional bevacizumab in patients with human immunodeficiency virus-associated Kaposi's sarcoma in the upper airway.

about

Confusion in the Study of Immune Reconstitution Inflammatory Syndrome.

P2860

Q33920429-B7FFCF38-7E8C-4BA7-B27A-CAA9EF205962

P2860

Intralesional bevacizumab in patients with human immunodeficiency virus-associated Kaposi's sarcoma in the upper airway.

Item

http://www.wikidata.org/entity/Q41688628

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Intralesional bevacizumab in p ...... s sarcoma in the upper airway.

@en

type

Item

label

Intralesional bevacizumab in p ...... s sarcoma in the upper airway.

@en

prefLabel

Intralesional bevacizumab in p ...... s sarcoma in the upper airway.

@en

P1476

Intralesional bevacizumab in p ...... s sarcoma in the upper airway.

@en

P2093

Christopher E Ormsby

http://www.w3.org/2001/XMLSchema#string

Claudia Alvarado-de la Barrera

http://www.w3.org/2001/XMLSchema#string

Gustavo Reyes-Terán

http://www.w3.org/2001/XMLSchema#string

Matilde Ruiz-Cruz

http://www.w3.org/2001/XMLSchema#string

Yuria Ablanedo-Terrazas

http://www.w3.org/2001/XMLSchema#string

P2860

Mesenchymal-to-endothelial transition in Kaposi sarcoma: a histogenetic hypothesis based on a case series and literature review

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults.

Kaposi's sarcoma herpesvirus K15 protein contributes to virus-induced angiogenesis by recruiting PLCγ1 and activating NFAT1-dependent RCAN1 expression.

Highly active antiretroviral therapy in AIDS-associated Kaposi's sarcoma: implications for the design of therapeutic trials in patients with advanced, symptomatic Kaposi's sarcoma.

Vascular endothelial growth factor: basic science and clinical progress.

Immune reconstitution and risk of Kaposi sarcoma and non-Hodgkin lymphoma in HIV-infected adults.

Intralesional vinblastine vs. 3% sodium tetradecyl sulfate for the treatment of oral Kaposi's sarcoma. A double blind, randomized clinical trial.

Phase II study of bevacizumab in patients with HIV-associated Kaposi's sarcoma receiving antiretroviral therapy.

Evidence for multiclonality in multicentric Kaposi's sarcoma.

P304

E132-7

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/LARY.24988

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

125

http://www.w3.org/2001/XMLSchema#string

P577

2014-10-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25345840

http://www.w3.org/2001/XMLSchema#string

P921

bevacizumab

Intralesional bevacizumab in patients with human immunodeficiency virus-associated Kaposi's sarcoma in the upper airway.

about

P2860

P2860

Intralesional bevacizumab in patients with human immunodeficiency virus-associated Kaposi's sarcoma in the upper airway.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921